BIO-TECHNE Corp (TECH) revenue by segment
TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 12/3051% above fair value
$72.63−0.16 (-0.22%)
Close on Nov 17, 2026Market cap $11.41BP/E 62.6Yield 0.44%
Doanh thu theo bộ phận của BIO-TECHNE Corp
Periods
Theo bộ phận kinh doanh
| Doanh thu | FY2026CY2026 | FY2025CY2025 | FY2024CY2024 | FY2023CY2023 | FY2022CY2022 | FY2021CY2021 | FY2020CY2020 | FY2019CY2019 | FY2018CY2018 | FY2017CY2017 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Protein Sciences | $874.62M | $870.25M | $830.90M | $845.75M | $832.31M | $704.56M | $555.35M | $543.16M | $482.38M | $419.37M | 72.0% | +0.5% |
| Diagnostics and Spatial Biology | $336.37M | $346.26M | $326.39M | $292.60M | – | – | – | – | – | – | 27.7% | -2.9% |
| Other Revenues from Business Held for Sale | – | – | $4.15M | – | – | – | – | – | – | – | – | – |
| Diagnostics and Genomics | – | – | $326.39M | $292.60M | $274.84M | $227.74M | $184.55M | $171.67M | $161.15M | $143.74M | – | – |
| Biotechnology | – | – | – | – | – | – | – | – | $421.54M | $364.50M | – | – |
| Protein Platforms | – | – | – | – | – | – | – | – | $111.89M | $91.46M | – | – |
| Diagnostics | – | – | – | – | – | – | – | – | $110.11M | $107.14M | – | – |
| Lợi nhuận hoạt động | FY2026CY2026 | FY2025CY2025 | FY2024CY2024 | FY2023CY2023 | FY2022CY2022 | FY2021CY2021 | FY2020CY2020 | FY2019CY2019 | FY2018CY2018 | FY2017CY2017 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Protein Sciences | $359.40M | $370.35M | $354.78M | $373.68M | $377.62M | $330.23M | $234.93M | $240.92M | $209.88M | $184.10M | -3.0% |
| Diagnostics and Spatial Biology | $37.70M | $21.32M | $24.55M | $43.04M | – | – | – | – | – | – | +76.8% |
| Diagnostics and Genomics | – | – | $24.55M | $43.04M | $48.98M | $38.43M | $14.97M | $10.08M | $35.50M | $29.29M | – |
| Biotechnology | – | – | – | – | – | – | – | – | $199.10M | $175.16M | – |
| Protein Platforms | – | – | – | – | – | – | – | – | $18.00M | $9.65M | – |
| Diagnostics | – | – | – | – | – | – | – | – | $28.28M | $28.58M | – |
Theo sản phẩm hoặc dịch vụ
| Doanh thu | FY2026CY2026 | FY2025CY2025 | FY2024CY2024 | FY2023CY2023 | FY2022CY2022 | FY2021CY2021 | FY2020CY2020 | FY2019CY2019 | FY2018CY2018 | FY2017CY2017 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product and Services | $1.19B | $1.20B | $1.14B | $1.12B | $1.08B | $912.18M | $721.56M | $694.57M | $630.66M | $547.94M | 97.9% | -0.5% |
| Consumables | $985.12M | $972.29M | $928.18M | $917.73M | $890.87M | $751.99M | $602.64M | $588.98M | $534.74M | $476.54M | 81.1% | +1.3% |
| Instruments | $110.63M | $112.09M | $108.27M | $112.09M | $120.76M | $93.78M | $71.46M | $67.54M | $61.78M | $47.75M | 9.1% | -1.3% |
| Services | $94.30M | $111.57M | $99.27M | $85.78M | $71.99M | $66.42M | $47.46M | $38.05M | $34.14M | $23.65M | 7.8% | -15.5% |
| Royalty revenues | $24.99M | $23.69M | $23.35M | $21.10M | $21.98M | $18.85M | $17.13M | $19.44M | $12.33M | $15.06M | 2.1% | +5.5% |
Theo khu vực
| Doanh thu | FY2026CY2026 | FY2025CY2025 | FY2024CY2024 | FY2023CY2023 | FY2022CY2022 | FY2021CY2021 | FY2020CY2020 | FY2019CY2019 | FY2018CY2018 | FY2017CY2017 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $635.37M | $683.23M | $657.75M | $642.47M | $614.11M | $502.08M | $404.41M | $391.19M | $346.29M | $313.20M | 52.3% | -7.0% |
| EMEA, excluding United Kingdom | $294.22M | $266.31M | $241.43M | $220.23M | $219.06M | $204.26M | $155.29M | $155.82M | $148.60M | $125.13M | 24.2% | +10.5% |
| China | $104.06M | $100.46M | $99.47M | $113.87M | $112.44M | $87.56M | $68.79M | $57.80M | $47.95M | $39.08M | 8.6% | +3.6% |
| APAC, excluding Greater China | $85.82M | $77.26M | $73.90M | $73.19M | $76.14M | $69.01M | $60.36M | $52.91M | $48.39M | $41.46M | 7.1% | +11.1% |
| United Kingdom | $56.28M | $54.83M | $50.01M | $49.46M | $48.64M | $40.95M | $30.41M | $34.98M | $33.70M | $28.40M | 4.6% | +2.7% |
| Rest of World | $39.29M | $37.55M | $36.50M | $37.49M | $35.22M | $27.17M | $19.43M | $21.31M | $18.06M | $15.74M | 3.2% | +4.6% |
Lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K, 10-Q của Bio-Techne (XBRL). Số quý 4 bằng cả năm tài chính trừ chín tháng đầu. Tên bộ phận giữ theo cách công ty tự đặt và có thể đổi khi công ty tái cấu trúc. Tab KPI hiện các bộ phận này cạnh chỉ số vận hành của Bio-Techne, kèm đầy đủ lịch sử, biểu đồ và liên kết tới từng hồ sơ.
See a number that looks wrong?